Cullinan Therapeutics: Fourth Quarter Earnings Overview

Cullinan Therapeutics Reports Fourth Quarter Financial Results

Cullinan Therapeutics, Inc., headquartered in Cambridge, Massachusetts, announced a net loss of $50.7 million for the fourth quarter.

The company stated that this equates to a loss of 77 cents per share.

These figures were better than what analysts had anticipated. According to a survey by Zacks Investment Research involving seven analysts, the consensus estimate was a loss of 80 cents per share.

For the entire year, Cullinan Therapeutics posted a total loss of $219.9 million, translating to $3.36 per share.

This article was produced by Automated Insights using data provided by Zacks Investment Research.